Genome-wide studies define new genetic mechanisms of IgA vasculitis
Lili Liu,Li Zhu,Sara Monteiro-Martins,Aaron Griffin,Lukas J. Vlahos,Masashi Fujita,Cecilia Berrouet,Francesca Zanoni,Maddalena Marasa,Jun Y. Zhang,Xu-jie Zhou,Yasar Caliskan,Oleh Akchurin,Samhar Al-Akash,Augustina Jankauskiene,Monica Bodria,Aftab Chishti,Ciro Esposito,Vittoria Esposito,Donna Claes,Vladimir Tesar,Thomas K. Davis,Dmitry Samsonov,Dorota Kaminska,Tomasz Hryszko,Gianluigi Zaza,Joseph T. Flynn,Franca Iorember,Francesca Lugani,Dana Rizk,Bruce A. Julian,Guillermo Hidalgo,Mahmoud Kallash,Luigi Biancone,Antonio Amoroso,Luisa Bono,Laila-Yasmin Mani,Bruno Vogt,Fangming Lin,Raji Sreedharan,Patricia Weng,Daniel Ranch,Nianzhou Xiao,Alejandro Quiroga,Raed Bou Matar,Michelle Rheault,Scott Wenderfer,Dave Selewski,Sigrid Lundberg,Cynthia Silva,Sherene Mason,John D. Mahan,Tetyana Vasylyeva,Krzysztof Mucha,Bartosz Foroncewicz,Leszek Pączek,Michał Florczak,Małgorzata Olszewska,Agnieszka Grańdziska,Maria Szczepańska,Edyta Machura,Andrzej Badeński,Helena Krakowczyk,Przemysław Sikora,Norbert Kwella,Monika Miklaszewska,Dorota Drożdż,Marcin Zaniew,Krzysztof Pawlaczyk,Katarzyna Siniewicz-Luzeńczyk,Andrew S. Bomback,Gerald B. Appel,Claudia Izzi,Francesco Scolari,Anna Materna-Kiryluk,Malgorzata Mizerska-Wasiak,Laureline Berthelot,Evangeline Pillebout,Renato C. Monteiro,Jan Novak,Todd Jason Green,William Smoyer,M. Colleen Hastings,Robert J. Wyatt,Raoul Nelson,Javier Martin,Miguel A. González-Gay,Phillip De Jager,Anna Kottgen,Andrea Califano,Ali G. Gharavi,Hong Zhang,Krzysztof Kiryluk
DOI: https://doi.org/10.1101/2024.10.10.24315041
2024-10-11
Abstract:IgA vasculitis (IgAV) is a pediatric disease with skin and systemic manifestations. Here, we conducted genome, transcriptome, and proteome-wide association studies in 2,170 IgAV cases and 5,928 controls, generated IgAV-specific maps of gene expression and splicing from blood of 255 pediatric cases, and reconstructed myeloid-specific regulatory networks to define disease master regulators modulated by the newly identified disease driver genes. We observed significant association at the HLA-DRB1 (OR=1.55, P=1.1x10-25) and fine-mapped specific amino-acid risk substitutions in DRβ1. We discovered two novel non-HLA loci: FCAR (OR=1.51, P=1.0x10-20) encoding a myeloid IgA receptor FcαR, and INPP5D (OR=1.34, P=2.2x10-09) encoding a known inhibitor of FcαR signaling. The FCAR risk locus co-localized with a cis-eQTL increasing FCAR expression; the risk alleles disrupted a PRDM1 binding motif within a myeloid enhancer of FCAR. Another risk locus was associated with a higher genetically predicted levels of plasma IL6R. The IL6R risk haplotype carried a missense variant contributing to accelerated cleavage of IL6R into a soluble form. Using systems biology approaches, we prioritized IgAV master regulators co-modulated by FCAR, INPP5D and IL6R in myeloid cells. We additionally identified 21 shared loci in a cross-phenotype analysis of IgAV with IgA nephropathy, including novel loci PAID4, WLS, and ANKRD55.